(EG) Everest - Ratings and Ratios
Reinsurance, Insurance, Property, Casualty, Specialty
Dividends
| Dividend Yield | 2.45% |
| Yield on Cost 5y | 3.88% |
| Yield CAGR 5y | 5.74% |
| Payout Consistency | 98.8% |
| Payout Ratio | 50.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.7% |
| Value at Risk 5%th | 38.4% |
| Relative Tail Risk | -1.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -16.68 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.260 |
| Beta | 0.477 |
| Beta Downside | 0.577 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.39% |
| Mean DD | 9.21% |
| Median DD | 9.16% |
Description: EG Everest October 30, 2025
Everest Group Ltd (NYSE: EG) operates two primary segments-Insurance and Reinsurance-offering a broad suite of property-and-casualty (P&C) products across the United States, Europe, and other international markets. The company writes both treaty and facultative reinsurance, covering specialty lines such as mortgage, catastrophe, marine, aviation, engineering, professional liability, credit & surety, motor, agriculture, and political-violence risks. Its insurance distribution channels include wholesale and retail brokers, surplus-lines brokers, and program administrators, while reinsurance is sold both through brokers and directly to ceding companies.
Key performance indicators from the most recent FY2023 filing show a net income of approximately $1.2 billion and a combined ratio near 95 %, indicating underwriting profitability that is modestly above the industry median of ~98 % for P&C reinsurers. The firm’s return on equity (ROE) hovered around 10 %, while investment income contributed roughly 30 % of total earnings, reflecting sensitivity to the prevailing high-interest-rate environment. Core sector drivers include the cyclical nature of catastrophe loss frequency, the ongoing hardening of reinsurance pricing cycles, and the impact of climate-change-related loss trends on underwriting margins.
For a deeper, data-rich assessment of EG’s valuation dynamics, you might explore ValueRay’s analytical platform, which aggregates granular financial and market metrics to help pinpoint high-expected-value opportunities.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (552.0m TTM) > 0 and > 6% of Revenue (6% = 1.05b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -2.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 59.61% (prev 62.41%; Δ -2.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 4.25b > Net Income 552.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.05b) to EBITDA (735.0m) ratio: 2.79 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (41.9m) change vs 12m ago -1.71% (target <= -2.0% for YES) |
| Gross Margin 9.36% (prev 21.44%; Δ -12.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 29.65% (prev 28.79%; Δ 0.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.83 (EBITDA TTM 735.0m / Interest Expense TTM 151.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.36
| (A) 0.17 = (Total Current Assets 11.45b - Total Current Liabilities 1.01b) / Total Assets 62.24b |
| (B) 0.26 = Retained Earnings (Balance) 16.20b / Total Assets 62.24b |
| (C) 0.01 = EBIT TTM 427.0m / Avg Total Assets 59.05b |
| (D) 0.34 = Book Value of Equity 16.05b / Total Liabilities 46.86b |
| Total Rating: 2.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.68
| 1. Piotroski 2.50pt |
| 2. FCF Yield data missing |
| 3. FCF Margin 24.25% |
| 4. Debt/Equity 0.23 |
| 5. Debt/Ebitda 2.79 |
| 6. ROIC - WACC (= -4.08)% |
| 7. RoE 3.78% |
| 8. Rev. Trend 94.13% |
| 9. EPS Trend -3.54% |
What is the price of EG shares?
Over the past week, the price has changed by +5.55%, over one month by +1.30%, over three months by -5.76% and over the past year by -7.62%.
Is EG a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 368.9 | 12.7% |
| Analysts Target Price | 368.9 | 12.7% |
| ValueRay Target Price | 321.4 | -1.8% |
EG Fundamental Data Overview December 11, 2025
P/E Trailing = 23.09
P/E Forward = 5.2383
P/S = 0.7375
P/B = 0.842
P/EG = -50.0
Beta = 0.38
Revenue TTM = 17.51b USD
EBIT TTM = 427.0m USD
EBITDA TTM = 735.0m USD
Long Term Debt = 3.59b USD (from longTermDebt, last quarter)
Short Term Debt = 2.35b USD (from shortTermDebt, last fiscal year)
Debt = 3.59b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.05b USD (from netDebt column, last quarter)
Enterprise Value = -3.60b USD (13.04b + Debt 3.59b - CCE 20.22b)
Interest Coverage Ratio = 2.83 (Ebit TTM 427.0m / Interest Expense TTM 151.0m)
FCF Yield = -118.0% (FCF TTM 4.25b / Enterprise Value -3.60b)
FCF Margin = 24.25% (FCF TTM 4.25b / Revenue TTM 17.51b)
Net Margin = 3.15% (Net Income TTM 552.0m / Revenue TTM 17.51b)
Gross Margin = 9.36% ((Revenue TTM 17.51b - Cost of Revenue TTM 15.87b) / Revenue TTM)
Gross Margin QoQ = 12.39% (prev 23.89%)
Tobins Q-Ratio = -0.06 (set to none) (Enterprise Value -3.60b / Total Assets 62.24b)
Interest Expense / Debt = 1.06% (Interest Expense 38.0m / Debt 3.59b)
Taxrate = 5.20% (14.0m / 269.0m)
NOPAT = 404.8m (EBIT 427.0m * (1 - 5.20%))
Current Ratio = 11.34 (Total Current Assets 11.45b / Total Current Liabilities 1.01b)
Debt / Equity = 0.23 (Debt 3.59b / totalStockholderEquity, last quarter 15.38b)
Debt / EBITDA = 2.79 (Net Debt 2.05b / EBITDA 735.0m)
Debt / FCF = 0.48 (Net Debt 2.05b / FCF TTM 4.25b)
Total Stockholder Equity = 14.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.89% (Net Income 552.0m / Total Assets 62.24b)
RoE = 3.78% (Net Income TTM 552.0m / Total Stockholder Equity 14.60b)
RoCE = 2.35% (EBIT 427.0m / Capital Employed (Equity 14.60b + L.T.Debt 3.59b))
RoIC = 2.23% (NOPAT 404.8m / Invested Capital 18.19b)
WACC = 6.31% (E(13.04b)/V(16.62b) * Re(7.77%) + D(3.59b)/V(16.62b) * Rd(1.06%) * (1-Tc(0.05)))
Discount Rate = 7.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.78%
[DCF Debug] Terminal Value 79.55% ; FCFE base≈4.63b ; Y1≈5.06b ; Y5≈6.43b
Fair Price DCF = 2667 (DCF Value 111.95b / Shares Outstanding 42.0m; 5y FCF grow 10.76% → 3.0% )
EPS Correlation: -3.54 | EPS CAGR: -4.95% | SUE: -0.69 | # QB: 0
Revenue Correlation: 94.13 | Revenue CAGR: 9.30% | SUE: 1.29 | # QB: 5
EPS next Quarter (2026-03-31): EPS=15.51 | Chg30d=-1.061 | Revisions Net=-8 | Analysts=14
EPS next Year (2026-12-31): EPS=55.60 | Chg30d=-4.720 | Revisions Net=-12 | Growth EPS=+24.7% | Growth Revenue=-6.4%
Additional Sources for EG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle